Abzena

Antitope is a wholly owned subsidiary of Abzena plc, a group focused on providing proprietary technologies and value-added services to enable the development of better biopharmaceuticals. Antitope provides immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins, and manufacturing cell line development. The Company provides its services and technologies to an international client base that includes most of the world's leading biotechnology and pharmaceutical companies.